APH Form 4: VP Exercises Options at $18.23 and Sells at $110.02

Rhea-AI Filing Summary

Michael R. Ivas, Amphenol Corporation's VP & Corporate Controller, reported an option exercise and an immediate sale of the resulting shares on 08/08/2025. He exercised 50,000 stock options at an exercise price of $18.23 and acquired 50,000 Class A shares, then sold 50,000 Class A shares at a weighted average sale price of $110.0164 (executed in multiple trades between $110.00 and $110.08). After these transactions the filing shows 152,412 shares beneficially owned directly by the reporting person and 0 stock options remaining. The filing also lists indirect holdings of 2,995 shares by children and 1,700 shares by spouse. The report documents conversion/exercise activity and a contemporaneous sale, reducing derivative holdings to zero while leaving a material direct ownership stake.

Positive

• Derivative holdings reduced to zero after exercise, removing this specific option overhang from the reporting person's position
• Reporting person retains a direct stake of 152,412 shares, indicating continued ownership interest
• Sale price disclosed as a weighted average ($110.0164) with trade range provided, improving transparency

Negative

• Insider sold 50,000 shares, which may be interpreted by some investors as partial monetization of holdings
• Reduction in derivative exposure means no remaining vested options from this grant to align future incentives from these specific awards

Insights

Securities Analyst

TL;DR: Officer exercised 50,000 options and sold 50,000 shares, leaving 152,412 direct shares and zero options outstanding.

The filing records a simultaneous exercise and sale on 08/08/2025: 50,000 options were exercised at $18.23 and 50,000 shares sold at a weighted average of $110.0164 in multiple trades. Post-transaction derivative holdings are reported as 0, eliminating this specific option overhang from the reporting person’s holdings. Direct beneficial ownership remains significant at 152,412 shares, and the report also discloses small indirect holdings by family members. This is a routine Section 16 disclosure of monetization of vested awards and does not by itself provide new operational or financial information about Amphenol.

Corporate Governance Expert

TL;DR: Routine insider exercise and sale disclosed; transaction details and residual ownership are clearly reported.

The Form 4 documents a clear chain of events: exercise of options granted earlier and an immediate sale of the acquired shares, with transaction pricing and the range of trade prices disclosed. The filing lists the reporting person’s role as VP & Corporate Controller and shows indirect family holdings, enhancing transparency about potential beneficial ownership. The form is focused on ownership changes and does not indicate any new corporate governance action or internal control change. Impact on shareholders is procedural rather than strategic.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ivas Michael R.

(Last) (First) (Middle)

C/O AMPHENOL CORPORATION

358 HALL AVENUE

(Street)

WALLINGFORD CT 06492

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMPHENOL CORP /DE/ [ APH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP & Corporate Controller

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/08/2025		M		50,000	A	$18.23	202,412	D
Class A Common Stock	08/08/2025		S		50,000	D	$110.0164(1)(2)	152,412	D
Class A Common Stock								2,995	I	By children
Class A Common Stock								1,700	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$18.23	08/08/2025		M			50,000	05/19/2018	05/19/2027	Class A Common Stock	50,000	$0	0	D

Explanation of Responses:

1. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. This transaction was executed in multiple trades ranging from $110.00 to $110.08

	/s/ Lance E. D'Amico, POA	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions does the APH Form 4 report?

Exercise of 50,000 options at $18.23 and sale of 50,000 shares at a weighted average $110.0164 on 08/08/2025.

How many APH shares does the reporting person own after these transactions?

152,412 shares beneficially owned directly following the reported transactions.

Are there any derivative securities remaining for the reporting person?

No; the filing reports 0 stock options beneficially owned following these transactions.

Does the filing disclose indirect holdings for the reporting person?

Yes. The filing shows 2,995 shares held by children and 1,700 shares held by spouse.

What price range were the shares sold in?

The explanatory note states the sale was executed in multiple trades ranging from $110.00 to $110.08.